Kane Biotech Inc (KNBIF) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Milestones

Yahoo FinanceDec 4 02:01 ET

Kane Biotech Narrows Its Third-Quarter Loss as Revenue Rises

MT NewswiresNov 28 16:44 ET

Kane Biotech Brief: Net Loss From Continuing Operations for the Third Quarter of 2024 Was $(678,636)

MT NewswiresNov 28 16:15 ET

Kane Biotech Reports Change in U.S. Distribution Partner for Revyve Gel

MT NewswiresNov 27 11:03 ET

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

GlobeNewswireNov 21 16:30 ET

Kane Biotech Announces Health Canada Approval of Revyve Antimicrobial Wound Gel

GlobeNewswireNov 14 13:10 ET